Cumin, particularly the Cuminum cyminum species, has gained attention for its health benefits, including its role in aiding digestion and relieving flatulence.

However, the Saudi Food and Drug Authority (SFDA) has urged consumers to seek medical advice regarding its use, particularly due to possible interactions with medications.

Cumin is a widely recognized aromatic spice used for seasoning, extracting oil for perfumes, and as part of traditional medicine practices.

In an advisory released on Thursday, the SFDA highlighted the necessity for caution when using herbs that may have therapeutic effects.

"Medical consultation is essential, as certain herbs may interact with medications or affect nutrient absorption," the SFDA stated.

The authority recommends a daily intake of cumin ranging from 1.5 to 3 grams, noting that one teaspoon is approximately 5 grams.

Concerns regarding cumin include its potential interactions with blood thinners and diabetes medications, which may mimic the effects of these treatments and lead to complications.

Medical advice is particularly advised for individuals with blood clotting disorders or diabetes, as well as for pregnant and lactating women.

The SFDA pointed out that cumin may induce uterine contractions, which could heighten the risk of premature birth, and reiterated that it might also influence hormonal balances during pregnancy.

Additionally, individuals may experience adverse effects such as acid reflux or diarrhea when consuming cumin.

In breastfeeding mothers, cumin consumption could affect milk production, potentially contributing to colic or diarrhea in infants.

The advisory further recommended that cumin be discontinued at least two weeks prior to any surgical procedure due to its potential to increase the risk of bleeding.